(Q74315105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

R J Mathvink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J S Tolman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Chitty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M R Candelore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M A Cascieri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L F Colwell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Deng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

W P Feeney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M J Forrest

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G J Hom

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D E MacIntyre

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Tota

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M J Wyvratt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M H Fisher

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A E Weber

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

number of pages

3

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1971-1973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

Pharmacological treatment of obesity: therapeutic strategies

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

Brown adipose tissue, beta 3-adrenergic receptors, and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

Beta3-adrenergic agonists: potential therapeutics for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailability.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

Potent, elective human beta3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900390-5

7 January 2021

10.1016/S0960-894X(00)00390-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987429%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference